These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21150284)

  • 1. Mucosal immunization: a realistic alternative.
    Otczyk DC; Cripps AW
    Hum Vaccin; 2010 Dec; 6(12):978-1006. PubMed ID: 21150284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface modified nanoparticulate carrier constructs for oral mucosal vaccine delivery.
    Mishra N; Singh D; Sharma S; Baldi A
    Curr Drug Deliv; 2014; 11(6):729-43. PubMed ID: 25007830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunization: a review of strategies and challenges.
    Patel H; Yewale C; Rathi MN; Misra A
    Crit Rev Ther Drug Carrier Syst; 2014; 31(4):273-303. PubMed ID: 25072196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in mucosal vaccine development.
    Chen H
    J Control Release; 2000 Jul; 67(2-3):117-28. PubMed ID: 10825547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting mucosal surfaces for the development of mucosal vaccines.
    Meeusen EN
    Vaccine; 2011 Nov; 29(47):8506-11. PubMed ID: 21945494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal delivery of vaccines in domestic animals.
    Gerdts V; Mutwiri GK; Tikoo SK; Babiuk LA
    Vet Res; 2006; 37(3):487-510. PubMed ID: 16611560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology solutions for mucosal immunization.
    Chadwick S; Kriegel C; Amiji M
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):394-407. PubMed ID: 19931581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines and mucosal immunisation.
    Cripps AW; Kyd JM; Foxwell AR
    Vaccine; 2001 Mar; 19(17-19):2513-5. PubMed ID: 11257385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery strategies to enhance mucosal vaccination.
    Chadwick S; Kriegel C; Amiji M
    Expert Opin Biol Ther; 2009 Apr; 9(4):427-40. PubMed ID: 19344280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery.
    Wang SH; Thompson AL; Hickey AJ; Staats HF
    Curr Top Microbiol Immunol; 2012; 354():121-56. PubMed ID: 21822816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.
    Anjuère F; Bekri S; Bihl F; Braud VM; Cuburu N; Czerkinsky C; Hervouet C; Luci C
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():117-22. PubMed ID: 22882377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal vaccines: Strategies and challenges.
    Li M; Wang Y; Sun Y; Cui H; Zhu SJ; Qiu HJ
    Immunol Lett; 2020 Jan; 217():116-125. PubMed ID: 31669546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
    Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
    APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.
    Nizard M; Diniz MO; Roussel H; Tran T; Ferreira LC; Badoual C; Tartour E
    Hum Vaccin Immunother; 2014; 10(8):2175-87. PubMed ID: 25424921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
    Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
    Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.
    Lawson LB; Norton EB; Clements JD
    Curr Opin Immunol; 2011 Jun; 23(3):414-20. PubMed ID: 21511452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues.
    Czerkinsky C; Holmgren J
    Curr Top Microbiol Immunol; 2012; 354():1-18. PubMed ID: 21053117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric controlled delivery for immunization.
    Kuntz RM; Saltzman WM
    Trends Biotechnol; 1997 Sep; 15(9):364-9. PubMed ID: 9293035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.